Novartis India Limited - Neraca (Quarterly)

Novartis India Limited
IN ˙ NSEI
Rs1.388,90 ↑37,70 (2,79%)
2026-06-05
HARGA SAHAM
Neraca (Quarterly)

Novartis India Limited Neraca menunjukkan saldo akun perusahaan pada waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Aset Tetap (APD), Persediaan, Barang Tak Berwujud, Kewajiban, Kewajiban Lancar, Hutang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Treasury, dan Ekuitas Pemegang Saham.

Semua angka dikalikan 1,000,000.00 kecuali per unit saham.

2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
2026
03-31
Uang tunai 5.135 1.584 5.651 194 4.901 5.961 5.972 521 6.173 6.677
Mengubah (%) -69,16 256,89 -96,56 2.423,53 21,63 0,19 -91,28 1.085,52 8,16
Aset Lancar 6.989 7.087 7.503 6.773 5.968 6.993 6.953 7.458 7.597 7.682
Mengubah (%) 1,40 5,87 -9,73 -11,89 17,17 -0,56 7,26 1,87 1,12
Aktiva 9.724 9.576 9.980 9.829 8.706 9.249 8.909 9.478 9.318 9.783
Mengubah (%) -1,53 4,22 -1,51 -11,43 6,24 -3,68 6,39 -1,69 4,98
Kewajiban 2.669 2.659 2.592 2.073 1.683 1.801 1.617 1.628 1.568 1.604
Mengubah (%) -0,38 -2,49 -20,04 -18,81 7,02 -10,24 0,73 -3,74 2,35
Ekuitas 7.055 6.917 7.387 7.757 7.023 7.448 7.292 7.850 7.751 8.178
Mengubah (%) -1,96 6,80 5,00 -9,46 6,06 -2,09 7,64 -1,26 5,52
Kewajiban dan Ekuitas Saham 9.724 9.576 9.980 9.829 8.706 9.249 8.909 9.478 9.318 9.783
Mengubah (%) -1,53 4,22 -1,51 -11,43 6,24 -3,68 6,39 -1,69 4,98

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
IN:500672 Rs1.388,90
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista